


Healthcare News Roundup: Regulatory
HSMN NewsFeed - 17 Jul 2013
Intarcia Therapeutics Appoints Dr. Eddie Li Vice President and Global Head of Regulatory Affairs
Intarcia Therapeutics Appoints Dr. Eddie Li Vice President and Global Head of Regulatory Affairs
HSMN NewsFeed - 16 Jul 2013
Misonix, Inc. Receives Clearance for the Sale of the BoneScalpel(TM) in the People's Republic of China
Misonix, Inc. Receives Clearance for the Sale of the BoneScalpel(TM) in the People's Republic of China
HSMN NewsFeed - 15 Jul 2013
Given Imaging's PillCam(R) COLON Cleared in Japan, World's Second Largest Healthcare Market
Given Imaging's PillCam(R) COLON Cleared in Japan, World's Second Largest Healthcare Market
HSMN NewsFeed - 10 Jul 2013
STENTYS Self-Apposing Stent Approved in Europe for Additional Coronary Indications
STENTYS Self-Apposing Stent Approved in Europe for Additional Coronary Indications
HSMN NewsFeed - 10 Jul 2013
Abbott Announces Approval of Next-Generation XIENCE Xpedition(TM) Drug Eluting Stent System in Japan
Abbott Announces Approval of Next-Generation XIENCE Xpedition(TM) Drug Eluting Stent System in Japan
HSMN NewsFeed - 8 Jul 2013
Market Access Granted in Italy for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI(R) (pixantrone)
Market Access Granted in Italy for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI(R) (pixantrone)
HSMN NewsFeed - 2 Jul 2013
ARIAD Announces Marketing Authorization for Iclusig(R) (ponatinib) in the European Union
ARIAD Announces Marketing Authorization for Iclusig(R) (ponatinib) in the European Union
HSMN NewsFeed - 28 Jun 2013
Genzyme Receives Positive CHMP Opinion for LEMTRADA(TM) (alemtuzumab) in Europe
Genzyme Receives Positive CHMP Opinion for LEMTRADA(TM) (alemtuzumab) in Europe
HSMN NewsFeed - 24 Jun 2013
AMAG Pharmaceuticals Appoints Steven Caffe, M.D. as Chief Development and Regulatory Officer
AMAG Pharmaceuticals Appoints Steven Caffe, M.D. as Chief Development and Regulatory Officer
HSMN NewsFeed - 24 Jun 2013
XTANDI(TM) (Enzalutamide) Authorized in the European Union for Advanced Prostate Cancer
XTANDI(TM) (Enzalutamide) Authorized in the European Union for Advanced Prostate Cancer
HSMN NewsFeed - 18 Jun 2013
Chembio's SURE CHECK(R) HIV 1/2 Assay for Rapid Point-of-Care Detection of HIV Receives CE Mark Approval
Chembio's SURE CHECK(R) HIV 1/2 Assay for Rapid Point-of-Care Detection of HIV Receives CE Mark Approval
HSMN NewsFeed - 10 Jun 2013
Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction
Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction
HSMN NewsFeed - 5 Jun 2013
Echo Therapeutics Initiates CE Mark Clinical Trial of its Symphony(R) CGM System
Echo Therapeutics Initiates CE Mark Clinical Trial of its Symphony(R) CGM System
HSMN NewsFeed - 29 May 2013
Teleflex Announces European Market Clearance for its Arrow(R) GPSCath(R) Balloon Dilatation Catheter
Teleflex Announces European Market Clearance for its Arrow(R) GPSCath(R) Balloon Dilatation Catheter
HSMN NewsFeed - 24 May 2013
PBAC Approves XIFAXAN(R) (Rifaxamin α) 550 mg Cost Effectiveness in Australia
PBAC Approves XIFAXAN(R) (Rifaxamin α) 550 mg Cost Effectiveness in Australia
HSMN NewsFeed - 23 May 2013
Astellas Receives Marketing Authorization for VESOMNI(TM) from the Netherlands Medicines Evaluation Board
Astellas Receives Marketing Authorization for VESOMNI(TM) from the Netherlands Medicines Evaluation Board
